Paclitaxel (P) (day 1 and 8) and carboplatin (C) given on every 3 weeks in advanced (stage III-IV) non-small cell lung cancer (NSCLC).

dc.contributor.author	YUMUK, PF
dc.contributor.author	TURHAL, NS
dc.contributor.author	HATABAY, NF
dc.contributor.author	TURKEN, O
dc.contributor.author	OZKAN, A
dc.contributor.author	SALEPCI, T
dc.contributor.author	ALIUSTAOGLU, M
dc.contributor.author	AHISKALI, R
dc.contributor.author	Ekenel, MELTEM
dc.contributor.author	GUMUS, Müjde Dila
dc.date.accessioned	2021-03-06T10:32:08Z
dc.date.available	2021-03-06T10:32:08Z
dc.identifier.citation	YUMUK P., TURHAL N., GUMUS M. D. , HATABAY N., TURKEN O., OZKAN A., SALEPCI T., ALIUSTAOGLU M., Ekenel M., AHISKALI R., "Paclitaxel (P) (day 1 and 8) and carboplatin (C) given on every 3 weeks in advanced (stage III-IV) non-small cell lung cancer (NSCLC).", 40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Haziran 2004, cilt.22
dc.identifier.other	vv_1032021
dc.identifier.other	av_eac5907c-1735-483d-a99b-f42816d27e73
dc.identifier.uri	http://hdl.handle.net/20.500.12627/154213
dc.language.iso	eng
dc.subject	Klinik Tıp (MED)
dc.subject	Onkoloji
dc.subject	Klinik Tıp
dc.subject	ONKOLOJİ
dc.subject	Tıp
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.title	Paclitaxel (P) (day 1 and 8) and carboplatin (C) given on every 3 weeks in advanced (stage III-IV) non-small cell lung cancer (NSCLC).
dc.type	Bildiri
dc.contributor.department	Marmara Üniversitesi , ,
dc.identifier.volume	22
dc.contributor.firstauthorID	88984

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.